Security key
462222100
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS)
CUSIP: 462222100
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 118,507,239
- Total 13F value
- $5,623,405,509
- Share change
- -1,612,954
- Put/Call ratio
- 128%
- SEC-reported price per share
- $47.45
- Number of holders
- 353
- Value change
- -$83,647,855
- Number of buys
- 146
- Number of sells
- 177
- Shares outstanding
- 166,460,189
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
353
Top holders
10
IONS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2020
Previous quarter: Q2 2020
IONIS PHARMACEUTICALS INC SEC filings
IONIS PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 462222100
Recent filing periods:
Ownership snapshot
Top reported holders of IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
13%
VANGUARD GROUP INC
7.4%
BlackRock Finance, Inc.
5.2%
PRICE T ROWE ASSOCIATES INC /MD/
5.2%
Bellevue Group AG
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
13%
|
$1,226,990,000
20,810,554 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
7.4%
|
$725,576,000
12,306,251 shares
|
— | 30 Jun 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
5.2%
|
$510,048,000
8,650,728 shares
|
— | 30 Jun 2020 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
5.2%
|
$507,726,000
8,611,362 shares
|
— | 30 Jun 2020 |
| Bellevue Group AG |
13F
Company
|
5%
|
$486,413,000
8,249,873 shares
|
— | 30 Jun 2020 |
| BAILLIE GIFFORD & CO |
13F
Company
|
4.9%
|
$484,575,000
8,218,699 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
353
Shares
118,507,239
Rows available
353
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
364
Q3 2020 holders
353
Holder diff
-11
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend